Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 4,256 Grace Therapeutics, Inc. shares (Form 4)

Traded Oct 19, 2026 · Filed Oct 21, 2026

On Oct 19, 2026, Opaleye Management Inc. (10% owner) bought 4,256 Grace Therapeutics, Inc. shares at US$1.88 for US$8,001, leaving 2,948,610 shares. Filed Oct 21, 2026 (Form 4).

Bought
4,256 shares
Price
US$1.88
Value
US$8,001
Holding after
2,948,610 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 19, 2026Common Stock, par value $0.0001 per shareBuy4,256US$1.882,948,610Indirect

Source

Download original · View original at SEC

Related